Dergiler / Laparoscopic Endoscopic Surgical Science / 2019 / Cilt: 26 - Sayı: 2

Effect of preoperative chemoradiotherapy on perioperative outcomes in patients undergoing laparoscopic rectal cancer surgery

Sayfa
55–60
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The classifiation of complications indicated Grade I, II, III, and IV complications in 16 (45.7%), 15 (42.8%), 3 (8.6%), and 1 (2.9%) patients, respectively, in the nCRT group as opposed to 16 (61.6%), 8 (30.8%), 1 (3.8%), and 1 (3.8%), respectively, in the non-nCRT group, and no signifiant difference was found between the 2 groups (p=0.606).Conclusion: The results indicated that nCRT had no effect on perioperative complications and resulted in longer operative times in laparoscopic rectal cancer surgery.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: The aim of this study was to investigate the effect of neoadjuvant chemoradiotherapy (nCRT) on perioperative outcomes in patients who underwent laparoscopic rectal cancer surgery.Materials and Methods: This retrospective study included patients who underwent laparoscopic surgery due to rectal adenocarcinoma between January 2017 and March 2019.
📊
Temel Bulgular & Veri:Perioperative complications were categorized according to the extended Clavien-Dindo classifiation.Results: The 61 patients enrolled in the study comprised 35 (57.4%) patients who received nCRT (nCRT group) and 26 (42.6%) patients who did not receive nCRT (non-nCRT group).
💡
Sonuç & Katkı:The classifiation of complications indicated Grade I, II, III, and IV complications in 16 (45.7%), 15 (42.8%), 3 (8.6%), and 1 (2.9%) patients, respectively, in the nCRT group as opposed to 16 (61.6%), 8 (30.8%), 1 (3.8%), and 1 (3.8%), respectively, in the non-nCRT group, and no signifiant difference was found between the 2 groups (p=0.606).Conclusion: The results indicated that nCRT had no effect on perioperative complications and resulted in longer operative times in laparoscopic rectal cancer surgery.
🔬Tür:Araştırma Makalesi
📍Kapsam:2017 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Introduction: The aim of this study was to investigate the effect of neoadjuvant chemoradiotherapy (nCRT) on perioperative outcomes in patients who underwent laparoscopic rectal cancer surgery.Materials and Methods: This retrospective study included patients who underwent laparoscopic surgery due to rectal adenocarcinoma between January 2017 and March 2019. Patients who underwent open surgery,transanal excision, or additional resection due to metastasis were excluded from the study. Demographic, clinical, and pathological characteristics of the patients were recorded. Perioperative complications were categorized according to the extended Clavien-Dindo classifiation.Results: The 61 patients enrolled in the study comprised 35 (57.4%) patients who received nCRT (nCRT group) and 26 (42.6%) patients who did not receive nCRT (non-nCRT group). The mean age was 54.6±12.9 years in the nCRT group and 62±14.8 years in the non-nCRT group, which represented a signifiant difference between the 2 groups (p=0.048). The groups were similar with regard to comorbidities, body mass index, American Society of Anesthesiologists score, pathological staging, and length of hospital stay. Themean operative time was 298±36.8 minutes in the nCRT group and 243±50.2 minutes in the non-nCRT group, which amounted to a signifiant difference (p<0.001). The classifiation of complications indicated Grade I, II, III, and IV complications in 16 (45.7%), 15 (42.8%), 3 (8.6%), and 1 (2.9%) patients, respectively, in the nCRT group as opposed to 16 (61.6%), 8 (30.8%), 1 (3.8%), and 1 (3.8%), respectively, in the non-nCRT group, and no signifiant difference was found between the 2 groups (p=0.606).Conclusion: The results indicated that nCRT had no effect on perioperative complications and resulted in longer operative times in laparoscopic rectal cancer surgery.

🔖

Bu Makaleye Atıf Yap

ADAY, U., BÖYÜK, A. (2019). Effect of preoperative chemoradiotherapy on perioperative outcomes in patients undergoing laparoscopic rectal cancer surgery. Laparoscopic Endoscopic Surgical Science, Cilt: 26 - Sayı: 2, 55–60. https://ajindex.com/articles/345104

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Ishihara S, Watanabe T, Fukushima Y, Akahane T, Horiuchi A, Shimada R, et al. Safety and factors contributing to the diffiulty of laparoscopic surgery for rectal cancer treated with preoperative chemoradiotherapy. Tech Coloproctol 2014;18:247–55
  2. Lu Y, Peng L, Ma Y, Liu Y, Ren L, Zhang L. Comparison Between Laparoscopic and Open Resection Following Neoadjuvant Chemoradiotherapy for Mid-Low Rectal Cancer Patients: A Meta-Analysis. J Laparoendosc Adv Surg Tech A 2019;29:316–22
  3. Rahbari NN, Elbers H, Askoxylakis V, Motschall E, Bork U, Büchler MW, et al. Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials. Ann Surg Oncol 2013;20:4169–82
  4. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731– 40
  5. Konishi T, Watanabe T, Kishimoto J, Nagawa H. Elective colon and rectal surgery differ in risk factors for wound infection: results of prospective surveillance. Ann Surg 2006;244:758– 63
  6. Marijnen CA, Kapiteijn E, van de Velde CJ, Martijn H, Steup WH, Wiggers T, et al; Cooperative Investigators of the Dutch Colorectal Cancer Group. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2002;20:817– 25
  7. Ahn BH, Lee KH, Park JB, Song MS, Kim JY, Kim JS. Shortterm outcomes after laparoscopic surgery following preoperative chemoradiotherapy for rectal cancer. J Korean Surg Soc 2012;83:281–7
  8. Zheng J, Feng X, Yang Z, Hu W, Luo Y, Li Y. The comprehensive therapeutic effects of rectal surgery are better in laparoscopy: a systematic review and meta-analysis. Oncotarget 2017;8:12717–29
  9. Chapman BC, Hosokawa P, Henderson W, Paniccia A, Overbey DM, Messersmith W, et al. Impact of neoadjuvant chemoradiation on perioperative outcomes in patients with rectal cancer. J Surg Oncol 2017;115:1033–44
  10. Valenti V, Hernandez-Lizoain JL, Baixauli J, Pastor C, Aristu J, Diaz-Gonzalez J, et al. Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy. Ann Surg Oncol 2007;14:1744–51
  11. Ulrich A, Weitz J, Slodczyk M, Koch M, Jaeger D, Münter M, et al. Neoadjuvant treatment does not influence perioperative outcome in rectal cancer surgery. Int J Radiat Oncol Biol Phys 2009;75:129–36
  12. Denoya